Opthamology news

Ciclosporin eye drops launched for keratitis
Increased reports of eye irritation with Xalatan

Increased reports of eye irritation with Xalatan

The risk of eye irritation in patients using Xalatan...

NICE recommends two treatments for diabetic macular oedema

NICE recommends two treatments for diabetic macular oedema

New guidance from NICE approves the use of aflibercept...

Tafluprost/timolol now available as combined glaucoma treatment

Tafluprost/timolol now available as combined glaucoma treatment

Taptiqom is a fixed-dose combination of the prostaglandin...

News in brief - October 2014 (updated)

News in brief - October 2014 (updated)

Other new launches, licence changes and updates relevant...

Simbrinza: new combination glaucoma treatment

Simbrinza: new combination glaucoma treatment

Simbrinza (brinzolamide/brimonidine) is licensed for...

Neoral approved for treatment of sight-threatening uveitis

Neoral approved for treatment of sight-threatening uveitis

Neoral (ciclosporin) can now be used for severe refractory...

News in brief - January 2014

News in brief - January 2014

Other new launches, licence changes and updates relevant...

Latest approvals from the SMC

Latest approvals from the SMC

Positive opinions on Lyxumia (lixisenatide), Sayana...

News in brief - September 2013

News in brief - September 2013

Other new launches, licence changes and updates relevant...

NICE recommends aflibercept for AMD

NICE recommends aflibercept for AMD

New guidance from NICE approves the use of aflibercept...

New advice from the SMC

New advice from the SMC

The Scottish Medicines Consortium has issued its latest...

Iluvien: intravitreal corticosteroid implant for diabetic macular oedema

Iluvien: intravitreal corticosteroid implant for diabetic macular oedema

Alimera has launched an intravitreal implant containing...

Jetrea: first pharmacological treatment for vitreomacular adhesion

Jetrea: first pharmacological treatment for vitreomacular adhesion

Jetrea (ocriplasmin) is an intravitreal injection for...

Ranibizumab gains NICE approval for secondary macular oedema

Ranibizumab gains NICE approval for secondary macular oedema

Ranibizumab (Lucentis) can now be prescribed in the...

Monopost: first preservative-free latanoprost eye drops

Monopost: first preservative-free latanoprost eye drops

Spectrum-Thea Pharmaceuticals has launched Monopost,...

NICE amends ranibizumab guidance

NICE amends ranibizumab guidance

NICE has overturned its original decision to reject...

Eylea: intravitreal injection for macular degeneration

Eylea: intravitreal injection for macular degeneration

Eylea (aflibercept) is licensed for the treatment of...

New recommendations published by the SMC

New recommendations published by the SMC

Positive opinions for a parenteral hypoglycaemic, an...

Nevanac licensed for diabetic indication

Nevanac licensed for diabetic indication

Nevanac (nepafenac) is now indicated to reduce the...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.